Accepting applications until August 1
Accepting applications until August 1
Zhuang Li, Penglin Liu, Aijun Yin,et al. Int. J. Cancer. 2025;157:288–297
Cervical cancer remains a major public health challenge worldwide, despite being largely preventable through effective interventions. Timely evidence regarding the global landscape of cervical cancer is crucial for measuring the m... Read More
Jiajie Zhou, Qizhi Yang, Shuai Zhao,et al. Ageing Res Rev. 2025 Feb:104:102666
Presently, colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. We provided global, regional, and national estimates of the burden of CRC and their attributable risks from 1990 to 2021, aiming to... Read More
C. Santucci, S. Mignozzi, M. Malvezzi, et al. Ann Oncol. 2024 Mar;35(3):308-316
We predicted cancer mortality figures for 2024 for the European Union (EU), its five most populous countries, and the UK. We predicted cancer mortality figures for 2024 for the European Union (EU), its five most populous countries... Read More
Takahisa Matsuda, Ai Fujimoto, Yoshinori Igarashi . Digestion. 2025;106(2):91-99
Colorectal cancer (CRC) is a significant global health issue, ranking as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths. Countries with a high Human Development Index (HDI) report th... Read More
Jianjiu Chen, and Wan Yang. JNCI Cancer Spectrum, 2024, 8(4), pkae052
Incidence of early-onset colorectal cancer (CRC) has increased globally in recent decades. We examined early-onset CRC incidence trends worldwide for potential cohort effects, defined as changes associated with time of birth (eg,... Read More
Pedro Nascimento de Lima , Lillian Bartholomew , Folasade P May, et al. J Natl Cancer Inst. 2026 Feb 1;118(2):360-363
Colorectal cancer (CRC) screening accounts for over 60% of cancer screening costs in the United States, prompting recurrent debates about its value. Yet CRC screening remains the main tool to curb overall CRC incidence, mortality,... Read More
Julio Garcia-Aguilar 1, Sujata Patil 2, Marc J Gollub 3, et al. J Clin Oncol. 2022 Aug 10;40(23):2546-2556
In this prospective, randomized phase II trial, we assessed the outcomes of 324 patients with stage II or III rectal adenocarcinoma treated with induction chemotherapy followed by chemoradiotherapy (INCT-CRT) or chemoradiotherapy... Read More
Elizabeth J Schafer, Mathieu Laversanne , Hyuna Sung , et al. Eur Urol. 2025 Mar;87(3):302-313
Our aim was to examine worldwide patterns and trends for prostate cancer (PC) incidence and mortality using high-quality, up-to-date, population-based data. Estimated PC rates across regions in 2022 varied 13-fold for incidence a... Read More
Nicholas D James, Ian Tannock, James N'Dow, et al. Lancet. 2024 Apr 27;403(10437):1683-1722
Prostate cancer is the most common cancer in men in 112 countries, and accounts for 15% of cancers. In this Commission, we report projections of prostate cancer cases in 2040 based on data for demographic changes worldwide and ris... Read More
Gisella Figlioli , Daniele Piovani , Andreas G Tsantes et al. Clinical Nutrition 48 (2025) 144e152
High body mass index (BMI) is a well-established cancer risk factor. Reliable, updated data are essential for guiding public health policies and designing effective interventions to reduce the cancer burden associated with high BM... Read More
Qiuxia Zhang , Jia Feng , Zhijie Xu, et al. Public Health. 2025 May:242:388-398
A strong association between high Body Mass Index (BMI) and Colorectal Cancer (CRC) has been well established. This study aims to examine and analyze the burden of CRC linked to high BMI at global, regional, and national levels fr... Read More
Yuzhou Cai , Ying Ye , Jingxian Qian. Public Health. 2025 May:242:340-351
This study aimed to assess global, regional, and national trends in breast cancer burden attributable to high body mass index (BMI) from 1990 to 2021 and provide projections up to 2036 using data from the Global Burden of Disease... Read More